Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
Open Access
- 9 December 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 397 (10268), 39-50
- https://doi.org/10.1016/s0140-6736(20)32541-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaThe Journal of Infectious Diseases, 2021
- Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, July 2019-February 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceCell Host & Microbe, 2020
- Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimizationnpj Vaccines, 2020
- The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 studyThe Lancet, 2019
- The Evolutionary Pathway to Virulence of an RNA VirusCell, 2017
- Update on Vaccine-Derived Polioviruses — Worldwide, January 2015–May 2016Morbidity and Mortality Weekly Report (MMWR), 2016
- Standardized Methods for Detection of Poliovirus AntibodiesPublished by Springer Science and Business Media LLC ,2016
- Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global BurdenThe Journal of Infectious Diseases, 2014
- Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray HybridizationJournal of Clinical Microbiology, 2005